Study Design. Retrospective review of a prospective cohortObjective. To determine the incidence and risk factors for 30-day morbidity and mortality following pediatric deformity spinal surgery.Summary of Background Data. Pediatric deformity spinal surgery is generally considered a safe and effective treatment option. The rising costs associated with spinal surgery and related peri-operative complications have received national attention. Few studies with standardized definitions and data collection methods exist.Methods. A large, multi-center clinical registry specifically designed to collect pediatric surgical outcomes was queried for all patients undergoing spinal deformity surgery in 2012. CPT codes were used to select patients undergoing anterior, posterior, and combined fusions. Detailed patient and case characteristics were analyzed. Thirty-day morbidity and mortality rates were calculated. Univariate and multivariate logistic regression analysis was used to identify patient characteristics, comorbidities, and operative variables predictive of complication.Results. In total, 2,005 pediatric patients undergoing deformity spinal fusion were included. The rate of 30-day complications was 10.0%; with a mortality rate of 0.15% (3 patients), a morbidity rate of 8.4%, reoperation rate of 3.74%, and readmission rate of 3.94%. Morbidity was highest in the Neuromuscular group (13.09%) and lowest in the Idiopathic cohort (5.69%), p < 0.01). Compared to posterior fusions, anterior fusions and those extending to the pelvis were associated with higher complication rates (p < 0.01). Risk factors for complication included hepatobiliary disease (p = 0.03), cognitive impairment (p = 0.02), elevated ASA Class (p<0.01), and prolonged operative time (p<0.01).Conclusion. The overall rate of 30-day morbidity after pediatric spinal deformity surgery was 10%. Multiple patient comorbidities and surgical duration and invasiveness were associated with an increased complication risk. This data may aid in the informed consent process, facilitate patient risk assessment, and allow quality comparisons between surgeons and institutions.
Pharmacology, Toxicology and Pharmaceutical Science
2
2%
Other
7
7%
Unknown
20
19%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2014.
All research outputs
#16,045,990
of 25,371,288 outputs
Outputs from Spine
#5,247
of 8,450 outputs
Outputs of similar age
#131,770
of 242,344 outputs
Outputs of similar age from Spine
#56
of 122 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,450 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,344 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
